These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 12110385)
1. Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation. Ficarra R; Tommasini S; Raneri D; Calabrò ML; Di Bella MR; Rustichelli C; Gamberini MC; Ficarra P J Pharm Biomed Anal; 2002 Aug; 29(6):1005-14. PubMed ID: 12110385 [TBL] [Abstract][Full Text] [Related]
2. Structural Investigation of Hesperetin-7- Kapoor MP; Moriwaki M; Minoura K; Timm D; Abe A; Kito K Molecules; 2022 Aug; 27(17):. PubMed ID: 36080157 [TBL] [Abstract][Full Text] [Related]
3. Preparation and spectroscopic studies of an inclusion complex of adenine with beta-cyclodextrin in solution and in the solid state. Hao X; Liang C; Jian-Bin C Analyst; 2002 Jun; 127(6):834-7. PubMed ID: 12146920 [TBL] [Abstract][Full Text] [Related]
4. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. Pralhad T; Rajendrakumar K J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147 [TBL] [Abstract][Full Text] [Related]
5. Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. Bayomi MA; Abanumay KA; Al-Angary AA Int J Pharm; 2002 Aug; 243(1-2):107-17. PubMed ID: 12176299 [TBL] [Abstract][Full Text] [Related]
6. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. Patel SG; Rajput SJ AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053 [TBL] [Abstract][Full Text] [Related]
8. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug. Aloisio C; Gomes de Oliveira A; Longhi M Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444 [TBL] [Abstract][Full Text] [Related]
9. Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins. Paczkowska M; Mizera M; Sałat K; Furgała A; Popik P; Knapik-Kowalczuk J; Krause A; Szymanowska-Powałowska D; Fojud Z; Kozak M; Paluch M; Cielecka-Piontek J Sci Rep; 2018 Nov; 8(1):16184. PubMed ID: 30385844 [TBL] [Abstract][Full Text] [Related]
10. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A. Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811 [TBL] [Abstract][Full Text] [Related]
11. Investigation of inclusion complex of epothilone A with cyclodextrins. Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285 [TBL] [Abstract][Full Text] [Related]
12. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions. Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534 [TBL] [Abstract][Full Text] [Related]
13. Inclusion complexation of nimesulide with beta-cyclodextrins. Vavia PR; Adhage NA Drug Dev Ind Pharm; 1999 Apr; 25(4):543-5. PubMed ID: 10194611 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations. Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543 [TBL] [Abstract][Full Text] [Related]
15. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
16. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state. Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation, Giri BR; Lee J; Lim DY; Kim DW Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707 [TBL] [Abstract][Full Text] [Related]
18. Investigation of inclusion complex of cilnidipine with hydroxypropyl-β-cyclodextrin. Hu L; Zhang H; Song W; Gu D; Hu Q Carbohydr Polym; 2012 Nov; 90(4):1719-24. PubMed ID: 22944438 [TBL] [Abstract][Full Text] [Related]
19. Formation of host-guest complexes of β-cyclodextrin and perfluorooctanoic acid. Karoyo AH; Borisov AS; Wilson LD; Hazendonk P J Phys Chem B; 2011 Aug; 115(31):9511-27. PubMed ID: 21688796 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]